The role of influenza in the epidemiology of pneumonia

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Shrestha, Sourya ^a,b   Foxman, Betsy ^a   Berus, Joshua ^a   Van Panhuis, Willem G ^c   Steiner, Claudia ^d   Viboud, Cecile ^e   Rohani, Pejman ^e,f  

^a UNIVERSITY OF MICHIGAN   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^d AGENCY FOR HEALTHCARE RESEARCH AND QUALITY   (United States)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

^f UNIVERSITY OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; INFLUENZA, HUMAN; ORTHOMYXOVIRIDAE; PATHOGENICITY; PATHOLOGY; PNEUMONIA; STATISTICAL MODEL; VIROLOGY;

HUMANS; INFLUENZA, HUMAN; LIKELIHOOD FUNCTIONS; ORTHOMYXOVIRIDAE; PNEUMONIA;

EID: 84944937682     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep15314     Document Type: Article

References (59)

1. WHO. World health organization. global health estimates: Disease burden. http://www.who.int/healthinfo/global-burden-disease/estimates-regional-2000-2011/en/index1.html (last accessed: March 20, 2015) (2013).
2. Lozano, R. et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of disease study 2010. The Lancet 380, 2095-2128 (2013).
3. Bosch, A. A. T. M., Biesbroek, G., Trzcinski, K., Sanders, E. A. M., Bogaert, D. Viral and bacterial interactions in the upper respiratory tract. PLoS Pathog. 9, e1003057 (2013).
4. Weinberger, D. M., Klugman, K. P., Steiner, C. A., Simonsen, L., Viboud, C. Association between Respiratory Syncytial Virus Activity and Pneumococcal Disease in Infants: A Time Series Analysis of US Hospitalization Data. PLoS Med. 12, e1001776 (2015).
5. Rudan, I., Boschi-Pinto, C., Biloglav, Z., Mulholland, K., Campbell, H. Epidemiology and etiology of childhood pneumonia. Bulletin of the World Health Organization 86, 408-416B (2008).
6. Falsey, A. R. et al. Bacterial complications of respiratory tract viral illness: A comprehensive evaluation. Journal of Infectious Diseases 208, 432-441 (2013). arXiv: http://jid.oxfordjournals.org/content/208/3/432.full.pdf+ html.
7. McCullers, J. A. Do specific virus-bacteria pairings drive clinical outcomes of pneumonia? Clinical Microbiology and Infection 19, 113-118 (2013).
8. McCullers, J. A. Insights into the interaction between influenza virus and pneumococcus. Clin. Microbiol. Rev. 19, 571-582 (2006).
9. McCullers, J. A. The co-pathogenesis of influenza viruses with bacteria in the lung. Nat Rev Micro 12, 252-262 (2014).
10. McCullers, J. A., Rehg, J. E. Lethal synergism between influenza virus and Streptococcus pneumoniae: Characterization of a mouse model and the role of platelet-activating factor receptor. J. Infect. Dis. 186, 341-350 (2002).
11. Sun, K., Metzger, D. M. Inhibition of pulmonary antibacterial defense by interferon-? during recovery from influenza infection. Nat. Med. 14, 558-564 (2008).
12. Kukavica-Ibrulj, I. et al. Infection with human metapneumovirus predisposes mice to severe pneumococcal pneumonia. J. Virol. 83, 1341-1349 (2009).
13. Shahangian, A. et al. Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice. J. Clin. Invest. 119, 1910-1920 (2009).
14. van der Sluijs, K. et al. IL-10 is an important mediator of the enhanced susceptibility to pneumococcal pneumonia after influenza infection. Journal of Immunology 172, 7603-7609 (2004).
15. Peltola, V., McCullers, J. Respiratory viruses predisposing to bacterial infections: role of neuraminidase. The Pediatric infectious disease journal 23, S87 (2004).
16. Avadhanula, V. et al. Respiratory viruses augment the adhesion of bacterial pathogens to respiratory epithelium in a viral speciesand cell type-dependent manner. Journal of Virology 80, 1629-1636 (2006). arXiv: http://jvi.asm.org/content/80/4/1629.full. pdf+ html.
17. Lee, L. N. et al. A mouse model of lethal synergism between influenza virus and Haemophilus influenzae. The American Journal of Pathology 176, 800-811 (2010).
18. Abramson, J. et al. Inhibition of neutrophil lysosome-phagosome fusion associated with influenza virus infection in vitro. role in depressed bactericidal activity. Journal of Clinical Investigation 69, 1393-1397 (1982).
19. Lee, M. et al. A postinfluenza model of Staphylococcus aureus pneumonia. The Journal of Infectious Diseases 201, 508-515 (2010).
20. Small, C. et al. Influenza infection leads to increased susceptibility to subsequent bacterial superinfection by impairing NK cell responses in the lung. The Journal of Immunology 184, 2048-2056 (2010).
21. Iverson, A. et al. Influenza virus primes mice for pneumonia from staphylococcus aureus. The Journal of Infectious Diseases 203, 880-888 (2011).
22. Broug-Holub, E. et al. Alveolar macrophages are required for protective pulmonary defenses in murine klebsiella pneumonia: elimination of alveolar macrophages increases neutrophil recruitment but decreases bacterial clearance and survival. Infection and Immunity 65, 1139-1146 (1997).
23. Rehm, S., Gross, G., Pierce, A. Early bacterial clearance from murine lungs. Species-dependent phagocyte response. Journal of Clinical Investigation 66, 194-199 (1980).
24. van der Sluijs, K., van der Poll, T., Lutter, R., Juffermans, N., Schultz, M. Bench-to-bedside review: Bacterial pneumonia with influenza-pathogenesis and clinical implications. Critical Care 14, 219 (2010).
25. Mina, M. J., Klugman, K. P. The role of influenza in the severity and transmission of respiratory bacterial disease. The Lancet Respiratory Medicine (2014).
26. Morens, D., Taubenberger, J., Fauci, A. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: Implications for pandemic influenza preparedness. J. Infect. Dis. 198, 962-970 (2008).
27. Brundage, J. Interactions between influenza and bacterial respiratory pathogens: implications for pandemic preparedness. Lancet Infect. Dis. 6, 303-312 (2006).
28. Louria, D., Blumenfeld, H., Ellis, J., Kilbourne, E., Rogers, D. Studies on influenza in the pandemic of 1957-1958. II. pulmonary complications of influenza. J. Clin. Invest. 38, 213-265 (1959).
29. Robertson, L., Caley, J., Moore, J. Importance of Staphylococcus aureus in pneumonia in the 1957 epidemic of influenza A. The Lancet 272, 233-236 (1958).
30. Lindsay Jr, M., Herrmann, Jr E., Morrow, Jr G., Brown, Jr A. Hong Kong influenza. Clinical, microbiologic, and pathologic features in 127 cases. JAMA 214, 1825-32 (1970).
31. Schwarzmann, S., Adler, J., Sullivan, Jr R., Marine, W. Bacterial pneumonia during the Hong Kong influenza epidemic of 1968-1969. Arch. Intern. Med. 127, 1037-1041 (1971).
32. Weinberger, D. et al. Impact of the 2009 influenza pandemic on pneumococcal pneumonia hospitalizations in the United States. J. Infect. Dis. 205, 458-465 (2012).
33. Walter, N. et al. Influenza circulation and the burden of invasive pneumococcal pneumonia during a non-pandemic period in the United States. Clin. Infect. Dis. 50, 175-183 (2010).
34. Kuster, S. P. et al. Evaluation of coseasonality of influenza and invasive pneumococcal disease: Results from prospective surveillance. PLoS Med. 8, e1001042 (2011).
35. Toschke, A. et al. No temporal association between influenza outbreaks and invasive pneumococcal infections. Arch. Dis. Child. 93, 218-220 (2008).
36. Smith, A. M. et al. Effect of 1918 PB1-F2 expression on influenza A virus infection kinetics. PLoS Computational Biology 7, e1001081 (2011).
37. McCullers, J. A. et al. Influenza enhances susceptibility to natural acquisition of and disease due to Streptococcus pneumoniae in ferrets. J. Infect. Dis. 202, 1287-1295 (2010).
38. Shrestha, S. et al. Identifying the interaction between influenza and pneumococcal pneumonia using incidence data. Science Translational Medicine 5, 191ra84 (2013). arXiv: http://stm.sciencemag.org/content/5/191/191ra84.full.pdf.
39. Shrestha, S. et al. Time and dose-dependent risk of pneumococcal pneumonia following influenza: a model for within-host interaction between influenza and Streptococcus pneumoniae. Journal of The Royal Society Interface 10, 20130233 (2013). arXiv: http://rsif.royalsocietypublishing.org/content/10/86/20130233.full.pdf+ html.
40. Soper, G. The pandemic in the army camps. JAMA 71, 1899 (1918).
41. Chien, Y.-W., Klugman, K. P., Morens, D. M. Bacterial pathogens and death during the 1918 influenza pandemic. New England Journal of Medicine 361, 2582-2583 (2009). PMID: 20032332, arXiv: http://www.nejm.org/doi/pdf/10.1056/NEJMc0908216.
42. Klugman, K. P., Chien, Y., Madhi, S. A. Pneumococcal pneumonia and influenza: A deadly combination. Vaccine 27S, C9-C14 (2009).
43. Weinberger, D. M. et al. Association of serotype with risk of death due to pneumococcal pneumonia: A meta-analysis. Clin. Infect. Dis. 51, 692-699 (2010).
44. Smith, A. M. et al. Kinetics of coinfection with influenza a virus and Streptococcus pneumoniae. PLoS Pathog 9, e1003238 (2013).
45. Francis, T. Transmission of influenza by a filterable virus. Science 80, pp. 457-459 (1934).
46. Ruuskanen, O., Lahti, E., Jennings, L. C., Murdoch, D. R. Viral pneumonia. The Lancet 377, 1264-1275 (2011).
47. Madhi, S., Klugman, K. et al. A role for Streptococcus pneumoniae in virus-associated pneumonia. Nature medicine 10, 811-813 (2004).
48. Mina, M. J., Klugman, K. P., McCullers, J. A. Live attenuated influenza vaccine, but not pneumococcal conjugate vaccine, protects against increased density and duration of pneumococcal carriage after influenza infection in pneumococcal colonized mice. Journal of Infectious Diseases 208, 1281-1285 (2013). arXiv: http://jid.oxfordjournals.org/content/208/8/1281.full.pdf+ html.
49. Katsura, H. et al. A bivalent vaccine based on a replication-incompetent influenza virus protects against streptococcus pneumoniae and influenza virus infection. Journal of Virology (2014). arXiv: http://jvi.asm.org/content/early/2014/09/04/JVI.01205-14.full. pdf+ html.
50. Yamin, D., Balicer, R. D., Galvani, A. P. Cost-effectiveness of influenza vaccination in prior pneumonia patients in israel. Vaccine 32, 4198-4205 (2014).
51. HCUP SID Database Documentation. Healthcare Cost and Utilization Project (HCUP), 2015. Agency for Healthcare Research and Quality, Rockville, MD. http://www.hcup-us.ahrq.gov/db/state/siddbdocumentation.jsp
52. Van Panhuis, W. G. et al. Contagious diseases in the united states from 1888 to the present. New England Journal of Medicine 369, 2152-2158 (2013). PMID: 24283231, arXiv: http://www.nejm.org/doi/pdf/10.1056/NEJMms1215400.
53. Anderson, R. M., May, R. M. Infectious Diseases of Humans; Dynamics and Control (Oxford University Press, Oxford, 1991).
54. Keeling, M., Rohani, P. Modelling Infectious Diseases (Princeton University Press, Princeton, 2008).
55. Ionides, E. L., Bretó, C., King, A. A. Inference for nonlinear dynamical systems. Proc. Natl. Acad. Sci. USA. 103, 18438-18443 (2006).
56. Ionides, E. L., Breto, C., King, A. A. Modeling Disease Dynamics: Cholera as a Case Study, chap. 8, 13-140 (Wiley, Hoboken NJ, 2007).
57. King, A. A., Ionides, E. L., Pascual, M., Bouma, M. J. Inapparent infections and cholera dynamics. Nature 454, 877-881 (2008).
58. Shrestha, S., King, A. A., Rohani, P. Statistical inference for multi-pathogen systems. PLoS Comput. Biol. 7, e1002135 (2011).
59. King, A. A. et al. pomp: Statistical inference for partially observed markov processes (R package). http://pomp.r.forge.r-project. org (2010).